HCV-Related central and peripheral nervous system demyelinating disorders

Inflammation and Allergy - Drug Targets

Volumn 13, Issue 5, 2014, Pages 299-304

  Mariotto, Sara ^a   Ferrari, Sergio ^a   Monaco, Salvatore ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Anti aquaporin 4; Anti MAG neuropathy; Demyelination; HCV; Neuromyelitis optica; Transverse myelitis

Indexed keywords

ALPHA INTERFERON; AQUAPORIN 4; AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MYELIN ASSOCIATED GLYCOPROTEIN; PROTEIN ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE MOTOR AXONAL NEUROPATHY; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DEMYELINATING DISEASE; DEMYELINATING NEUROPATHY; ENCEPHALOMYELITIS; GUILLAIN BARRE SYNDROME; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; PERIPHERAL NEUROPATHY; SPINAL CORD BIOPSY; ANIMAL; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM DISEASES; CHRONIC HEPATITIS C; COMPLICATION; DEMYELINATING DISEASES; HEPACIVIRUS; IMMUNOLOGY; NEUROMYELITIS OPTICA; PERIPHERAL NERVOUS SYSTEM DISEASES; VIROLOGY;

ANIMALS; AQUAPORIN 4; AUTOANTIBODIES; B-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM DISEASES; DEMYELINATING DISEASES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROMYELITIS OPTICA; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84924126904     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871528113666140908113841     Document Type: Article

References (43)

1. Lauer, G.M.; Walker, B.D. Hepatitis C virus infection. New Engl. J. Med., 2001, 345(1), 41-52.
2. Jacobson, I.M.; Cacoub, P.; Dal Maso, L.; Harrison, S.A.; Younossi, Z.M. Manifestations of chronic hepatitis C virus infection beyond the liver. Clin. Gastroenterol. Hepatol., 2010, 8(12), 1017-1029.
3. Monaco, S.; Ferrari, S.; Gajofatto, A.; Zanusso, G.; Mariotto, S. HCV-related nervous system disorders. Clin. Dev. Immunol., 2012, 236148.
4. Horner, S.M.; Gale, M.Jr. Regulation of hepatic innate immunity by hepatitis C virus. Nat. Med., 2013, 19(7), 879-888.
5. Tarr, A.W.; Urbanowicz, R.A.; Ball, J.K. The role of humoral innate immunity in hepatitis C virus infection. Viruses, 2012, 4(1), 1-27.
6. Himoto, T.; Masaki, T. Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin. Dev. Immunol., 2012, 871401.
7. Zignego, A.L.; Gragnani, L.; Giannini, C.; Laffi, G. The hepatitis C virus infection as a systemic disease. Intern. Emerg. Med., 2012, (Suppl 3), S201-208.
8. Kitada, M.; Suzuki, H.; Ichihashi, J.; Inada, R.; Miyamoto, K.; Takahashi, T.; Mitsui, Y.; Fujihara, K.; Kusunoki, S. Acute combined central and peripheral demyelination showing antiaquaporin 4 antibody positivity. Intern. Med., 2012, 51(17), 2443- 2447.
9. Latov, N.; Hays, A.P.; Sherman, W.H. Peripheral neuropathy and anti-MAG antibodies. Crit. Rev. Neurobiol., 1988, 3(4), 301-332.
10. Beh, S.C.; Greenberg, B.M.; Frohman, T.; Frohman, E.M. Transverse myelitis. Neurol. Clin., 2013, 31(1), 79-138.
11. Sobukawa, E.; Sakimura, K.; Hoshino, S.; Hoshino, M.; Miyoshi, K. Hepatic myelopathy: an unusual neurological complication of advanced hepatic disease. Intern. Med., 1994, 33(11), 718-722.
12. Zieve, L.; Mendelson, D.F.; Goepfert, M. Shunt encephalomyelopathy. II. Occurrence of permanent myelopathy. Ann. Intern. Med., 1960, 53, 53-63.
13. Nolte, C.H.; Endres, A.S.; Meisel, H. Sensory ataxia in myelopathy with chronic hepatitis C virus infection. Neurology, 2002, 59(6), 958.
14. Suzuki, K.; Takao, M.; Katayama, Y.; Mihara, B. Acute myelitis associated with HCV infection. BMJ Case Rep., 2013, 13, 2013.
15. Zandman-Goddard, G.; Levy, Y.; Weiss, P.; Shoenfeld, Y.; Langevitz, P. Transverse myelitis associated with chronic hepatitis C. Clin. Exp. Rheumatol., 2003, 21(1), 111-113.
16. Grewal, A.K.; Lopes, M.B.; Berg, C.L.; Bennett, A.K.; Alves, V.A.; Trugman, J.M. Recurrent demyelinating myelitis associated with hepatitis C viral infection. J. Neurol. Sci., 2004, 224(1-2), 101-106.
17. Annunziata, P.; Marroni, M.; Francisci, D.; Stagni, G. Acute transverse myelitis and hepatitis C virus. Infez. Med., 2005, 13(1), 45-47.
18. De Carli, D.M.; Pannebeker, J.; Pedro, F.L. Haygert, C.J.; Hertz, E.; Beck, Mde. O. Transverse myelitis associated to HCV infection. Braz. J. Infect. Dis., 2009, 13(2), 147-152.
19. Aktipi, K.M.; Ravaglia, S.; Ceroni, M.; Nemni, R.; Debiaggi, M.; Bastianello, S.; Alfonsi, E.; Zardini, E.; Minoli, L.; Tavazzi, E.; Marchioni, E. Severe recurrent myelitis in patients with hepatitis C virus infection. Neurology, 2007, 68(6), 468-469.
20. Takahashi-Fujigasaki, J.; Takagi, S.; Sakamoto, T.; Inoue K. Spinal cord biopsy findings of anti-aquaporin-4 antibody-negative recurrent longitudinal myelitis in a patient with sicca symptoms and hepatitis C viral infection. Neuropathology, 2009, 29(4), 472- 479.
21. Sacconi, S.; Salviati, L.; Merelli, E. Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch. Neurol., 2001, 58(10), 1679-1681.
22. Sim, J.E.; Lee, J.B.; Cho, Y.N.; Suh, S.H.; Kim, J.K.; Lee, K.Y. A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection. Yonsei. Med. J., 2012, 53(4), 856-858.
23. Bolay, H.; Söylemezoğlu, F.; Nurlu, G.; Tuncer, S.; Varli, K. PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin. Neurol. Neurosurg., 1996, 98(4), 305-308.
24. Guo, Y.; Lennon, V.A.; Popescu, B.F.; Grouse, C.K.; Topel, J.; Milone, M.; Lassmann, H.; Parisi, J.E.; Pittock, S.J.; Stefoski, D.; Balabanov, R.; Lucchinetti, C.F. Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum. JAMA Neurol., 2014, 71(8), 1025-1029.
25. Bonetti, B.; Scardoni, M.; Monaco, S.; Rizzuto, N.; Scarpa, A. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch., 1999, 434(6), 533-535.
26. Bonetti, B.; Monaco, S.; Giannini, C.; Ferrari, S.; Zanusso, G.; Rizzuto, N. Human peripheral nerve macrophages in normal and pathological conditions. J. Neurol. Sci., 1993, 118(2), 158-168.
27. De Klippel, N.; Hautekeete, M.L.; De Keyser, J.; Ebinger, G. Guillain-Barré syndrome as the presenting manifestation of hepatitis C infection. Neurology, 1993, 43(10), 2143.
28. Macleod, W.N. Sporadic non-A, non-B hepatitis and Epstein-Barr hepatitis associated with the Guillain-Barré syndrome. Arch. Neurol., 1987, 44(4), 438-242.
29. Tabor, E. Guillain-Barré syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B. J. Med. Virol., 1987, 21(3), 207-216.
30. Khiani, V.; Kelly, T.; Shibli, A.; Jensen, D.; Mohanty, S.R. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection. World J. Gastroenterol., 2008, 14(2), 318-321.
31. Lacaille, F.; Zylberberg, H.; Hagège, H.; Roualdès, B.; Meyrignac, C.; Chousterman, M.; Girot, R. Hepatitis C associated with Guillain-Barré syndrome. Liver, 1998, 18(1), 49-51.
32. Corcia, P.; Barbereau, D.; Guennoc, A.M.; de Toffol, B.; Bacq, Y. Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy. Neurology, 2004, 63(1), 179-180.
33. Harada, H.; Ohkoshi, N.; Fujita, Y.; Tamaoka, A.; Shoji, S. Clinical improvement following interferon-alpha alone as an initial treatment in CIDP. Muscle Nerve, 2000, 23(2), 295-296.
34. Marzo, M.E.; Tintoré, M.; Fabregues, O.; Montalbán, X.; Codina, A. Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha. J. Neurol. Neurosurg. Psychiatry., 1998, 65(4), 604.
35. Hirotani, M.; Nakano, H.; Ura, S.; Yoshida, K.; Niino, M.; Yabe, I.; Sasaki, H. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Intern. Med., 2009, 48(5), 373-375.
36. Meriggioli, M.N.; Rowin, J. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Muscle Nerve, 2000, 23(3), 433-435.
37. Couto, M.; Conceição, I.; de Carvalho, M. Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha. J. Peripher. Nerv. Syst., 2006, 11(4), 353-354.
38. Caporale, C.M.; Capasso, M.; Ragno, M.; Di Muzio, A.; Uncini, A. Lewis-Sumner syndrome in hepatitis C virus infection: a possible pathogenetic association with therapeutic problems. Muscle Nerve, 2006, 34(1), 116-121.
39. Monaco, S.; Bonetti, B.; Ferrari, S.; Moretto, G.; Nardelli, E.; Tedesco, F.; Mollnes, T.E.; Nobile-Orazio, E.; Manfredini, E.; Bonazzi, L.; Rizzuto, N. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N. Engl. J. Med., 1990, 322(10), 649-652.
40. Latov, N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nat. Rev. Neuro., 2014, doi: 10.1038/nrneurol.2014.117.
41. Thomas, F.P.; Lovelace, R.E.; Ding, X.S.; Sadiq, S.A.; Petty, G.W.; Sherman, W.H.; Latov, N.; Hays, A. P. Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IGM monoclonal gammopathy. Muscle Nerve, 1992, 15(8), 891-898.
42. Vital, A.; Favereaux, A.; Martin-Dupont, P.; Taupin, J.L.; Petry, K.; Lagueny, A.; Canron, M.H.; Vital, C. Anti-myelin-associated glycoprotein antibodies and endoneurial cryoglobulin deposits responsible for a severe neuropathy. Acta Neuropathol., 2001, 102(4), 409-412.
43. Alpa, M.; Ferrero, B.; Cavallo, R.; Naretto, C.; Menegatti, E.; Di Simone, D.; Napoli, F.; La Grotta, R.; Rossi, D.; Baldovino. S.; Sena, L.M.; Roccatello, D. Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia. Autoimmun. Rev., 2008, 8(1), 56-58.